BTAI - Investors in BioXcel Therapeutics Inc. (NASDAQ: BTAI) should contact the Shareholders Foundation in connection with a Lawsuit | Benzinga

SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI).

Investors, who purchased BioXcel Therapeutics, Inc. (NASDAQ:BTAI) shares prior to December 2021 and continue to hold any of those NASDAQ: BTAI shares, also have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On July 07, 2023, a lawsuit was filed by an investor in NASDAQ: BTAI shares against BioXcel Therapeutics, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants failed to disclose to investors that the Company lacked adequate internal ...

BTAI) should contact the Shareholders Foundation in connection with a Lawsuit>Full story available on Benzinga.com